Christophe Pierre Weber

Christophe Pierre Weber is a declared insider at 2 companies; the most frequent names are Takeda Pharmaceutical Co Ltd and Boston Scientific Corp. Between 2 March 2026 and 27 April 2026, the trades on record add up to 3 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

On 28 April 2026 came the latest disclosure, a share grant in Takeda Pharmaceutical Co Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.